Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fletcher's Laxative (formerly known as Fletcher's Castoria) is an over-the-counter stimulant laxative syrup developed and marketed by The Mentholatum Company, a subsidiary of Rohto Pharmaceutical. The active ingredient is senna pod concentrate, which contains natural plant compounds called sennosides. These sennosides act as stimulant laxatives by irritating the colonic mucosa and stimulating the myenteric plexus, which increases intestinal peristalsis and bowel motility. Fletcher's specifically utilizes senna pods rather than senna leaves, as pods are considered gentler on the digestive system. The product is indicated for the relief of occasional constipation in children ages 2 and up as well as adults, typically producing a bowel movement within 6 to 12 hours. The formulation features a root beer flavor to improve palatability for pediatric use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fletcher's Laxative.